US · Healthcare · Medical Instruments & Supplies
EPS came in at 0.56 against a street estimate of 0.36 — a beat of 55.6%.
Analysts rate Baxter International Inc a hold (6 buy, 11 hold, 1 sell out of 18) with an average price target of $27.29.
| Fund | Stake |
|---|---|
| BlackRock Inc | 15.36% |
| Pzena Investment Management, LLC | 12.48% |
| Dodge & Cox | 11.07% |
| FMR Inc | 8.95% |
| Vanguard Capital Management, LLC | 6.48% |
| Vanguard Portfolio Management, LLC | 4.64% |
| State Street Corp | 3.86% |
| Greenhaven Associates Inc | 2.76% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 | 2026-07-30 |
| Results announced · Q3 2026 | 2026-07-30 |
| Reg FD disclosure · Q3 2026 | 2026-07-14 |
| Board / officer change · Q2 2026 | 2026-05-08 |
| Quarterly report · Q1 2026 | 2026-04-30 |
| Results announced · Q2 2026 | 2026-04-30 |
| Proxy statement · Q2 2026 | 2026-03-23 |
| Annual report FY2025 | 2026-02-12 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Baxter International Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.